Lupus Trials
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
500 Bi County Blvd Ste 201, Farmingdale,...Phone Number
(631) 753-6300Website
www.lupustrials.orgRevenue
<$5 MillionIndustry
About Lupus Trials
Is Lupus Trials your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Lupus Trials has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Lupus Trials launches new products
Lupus Trials, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Lupus Trials has new funding data
Earning: See what the market has to say on Lupus Trials recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Lupus Trials had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Lupus Trials is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Lupus Trials
Recommended Actions
Find VP level buyers at Lupus Trials
Find 2 more new buyers
Compare Similar Companies to Lupus Trials
Compare insights from companies similar to Lupus Trials, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lupus Trials
Company Profile Activity
Activity Insights
Lupus Trials is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Lupus Trials is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Lupus Trials.
Lupus Trials Tech Stack
A closer look at the technologies used by Lupus Trials
Lupus Trials News & Media
LRA Applauds GSK on Positive Phase 3 Study of Benlysta® for Lupus Nephritis
NEW YORK, Sept. 16, 2020 /PRNewswire/ -- The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week's New England Journal of Medicine, demonstrating that GSK's drug BenlystaR (belimumab) significantly improved kidney function in adults with lupus nephritis,...PPD and Lupus Therapeutics Collaborate to Support Lupus Clinical Research
WILMINGTON, N.C.--(BUSINESS WIRE)--PPD and Lupus Therapeutics are collaborating to expand and enhance lupus clinical research for PPD’s pharmaceutical and biotech customersNew Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
The Lupus Research Alliance is encouraged by exciting news from GSK that Benlysta® (belimumab) demonstrated positive clinical trial results in treating lupus nephritis (LN), a common complication of lupus causing inflammation of the kidneys that can result in end-stage kidney disease. Called BLISS-LN, this trial is the largest one ever conducted among patients with lupus nephritis and paves the way for a new treatment for lupus nephritis.
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lupus Trials
Lupus Therapeutics is dedicated to advancing clinical research and care for the lupus community through various initiatives focused on health equity, education, and access to clinical trials. The organization collaborates with biopharmaceutical companies, clinical investigators, and community organizations to facilitate inclusive clinical research... Read More